GENENTECH INC FDA Approval Nov. 25, 2024, 09:49 UTC 50 0 comments FDA approve PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF Comment Full text
RISING FDA Approval Nov. 25, 2024, 09:49 UTC 48 0 comments FDA approve DOXERCALCIFEROL Comment Full text
AUROBINDO PHARMA FDA Approval Nov. 25, 2024, 09:49 UTC 45 0 comments FDA approve OMEPRAZOLE; SODIUM BICARBONATE Comment Full text
SENORES PHARMS FDA Approval Nov. 25, 2024, 09:49 UTC 58 0 comments FDA approve KETOROLAC TROMETHAMINE Comment Full text
NEXUS FDA Approval Nov. 25, 2024, 09:49 UTC 59 0 comments FDA approve METHYLENE BLUE Comment Full text
CHARTWELL RX FDA Approval Nov. 25, 2024, 09:49 UTC 46 0 comments FDA approve ISONIAZID Comment Full text
USWM FDA Approval Nov. 25, 2024, 09:49 UTC 45 0 comments FDA approve DANTROLENE SODIUM Comment Full text
SCIEGEN PHARMS INC FDA Approval Nov. 25, 2024, 09:49 UTC 54 0 comments FDA approve ESOMEPRAZOLE MAGNESIUM; NAPROXEN Comment Full text
MARKSANS PHARMA FDA Approval Nov. 25, 2024, 09:49 UTC 58 0 comments FDA approve LORATADINE Comment Full text
ALEMBIC FDA Approval Nov. 25, 2024, 09:49 UTC 51 0 comments FDA approve DICLOFENAC SODIUM Comment Full text